ACM
RPTP

Atika Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Atika Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-298,200
Closed -$2.67M – 86
2016
Q3 		$2.67M Sell
298,200
-1,059,800
-78% -$7.54M 1.09% 37
2016
Q2 		$7.29M Buy
+1,358,000
New +$6.96M 3.12% 6

Atika Capital Management's RPTP Position: Q4 2016 in Review

Atika Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 298,200 shares — an estimated $2.67M sold.

Atika Capital Management first reported a position in RPTP in Q2 2016 and held it in 2 quarters. The position peaked at $7.29M in Q2 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Atika Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Atika Capital Management sold 298,200 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $2.67M.
  • Atika Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2016 and held it in 2 quarters.
  • Atika Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $7.29M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Atika Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.